[at noodls] – SOUTH SAN FRANCISCO, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) said that the U.S. Food and Drug Administration (FDA) has advised the Company not to expect a final … moreView todays social media effects on HPTXView the latest stocks trending across Twitter. Click to view dashboardSee who Hyperion is hiring next, click here […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Nov. 12, 2012 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) announced today that the results of the Phase 2 HALT-HE Study were presented at the Presidential … moreView todays social media effects on HPTXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (NasdaqGM:HPTX) today reported consolidated financial results for the third quarter of 2012….This is an abstract … moreView todays social media effects on HPTXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) — Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at two investor conferences in November: Lazard … moreView todays social media effects on HPTXView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – SOUTH SAN FRANCISCO, Calif., Oct. 17, 2012 (GLOBE NEWSWIRE) — Hyperion Therapeutics, Inc. (Nasdaq:HPTX) announced today that the company will host and webcast an analyst and investor briefing on November … moreView todays social media effects on HPTXView the latest stocks trending across Twitter. Click to view dashboard […]
